DXCM DEADLINE REMINDER: DexCom, Inc. Investors who Lost Money are Reminded to Contact BFA Law before Upcoming Securities Litigation Deadline (Nasdaq:DXCM)
07 sept. 2024 07h16 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
Digital Marketing Trends in Type 2 Diabetes
03 sept. 2024 10h45 HE
|
Research and Markets
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Digital Marketing Trends in Type 2 Diabetes - April 2024" report has been added to ResearchAndMarkets.com's offering. This report provides an...
Fractyl Health to Participate in Upcoming September Investor Conferences
03 sept. 2024 07h00 HE
|
Fractyl Health, Inc.
Fractyl Health to Participate in Upcoming September Investor Conferences
DXCM STOCK NOTICE: DexCom, Inc. is being Sued for Securities Fraud; Contact BFA Law Now about the Lawsuit if You Lost Money on Your Investment (Nasdaq:DXCM)
03 sept. 2024 06h36 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
03 sept. 2024 06h30 HE
|
Embecta Corp.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.
DXCM STOCK NEWS: A Securities Fraud Class Action has been Filed Against DexCom, Inc. -- Contact BFA Law before October Deadline if You Suffered Losses (Nasdaq:DXCM)
01 sept. 2024 06h44 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
Connected Diabetes Care Innovations and Growth Opportunity Analysis 2024: Funding, Emerging Digital Diabetes Care Technologies, and Partnerships Shaping the Future of Global Diabetes Care
15 août 2024 06h28 HE
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Connected Diabetes Care: Innovations and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research provides...
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
08 août 2024 08h00 HE
|
Fractyl Health, Inc.
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
30 juil. 2024 07h00 HE
|
Fractyl Health, Inc.
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
[Latest] US Diabetes Devices Market Size/Share Worth USD 19.8 Billion by 2033 at a 7.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
23 juil. 2024 13h30 HE
|
Custom Market Insights
Austin, TX, USA, July 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Diabetes Devices Market Size, Trends and Insights By Type (Blood Glucose...